Finding Sustainability in Every Corner of the Economy

Assembly and Advent Transaction

William Blair acted as financial advisor to Assembly in connection with its strategic investment led by Advent International.

Anne Frank Art Contest Continues to Inspire

The annual Anne Frank Art Contest, sponsored by William Blair, drew more than 400 entries this spring from youth throughout Germany. This year’s theme was Pushing Boundaries.

Maggie Wilmouth

View biography for Maggie Wilmouth, Director, Consumer Products & Services.

Economics Weekly Debt Tariffs and Tax Cuts

In this Economics Weekly, we again examine the tariff question, but home in on how it relates to the market’s next major hurdle, which is extending the 2017 tax cuts, and the ultimate goal of all these changes, which is to bring down debt and restore confidence in U.S. public finances.

Russ Dunlap

View biography for Russ Dunlap, Managing Director, Tech Enabled Services.

Matthew Batterbury

View biography for Matthew Batterbury, Managing Director, Healthcare IT

Intellia Therapeutics Inc Initiation

William Blair initiated research coverage of Intellia Therapeutics, Inc. (NTLA $95.86), a clinical-stage genome-editing company focused on using CRISPR-Cas9 technology to create in vivo and ex vivo therapies for diseases with high unmet need.

9 Meters Biopharma Inc Initiation

William Blair & Company initiated research coverage of 9 Meters Biopharma, Inc. (NMTR $0.68). Created by the integration of three companies in May 2020, 9 Meters Biopharma is a clinical-stage biotechnology company focused on therapies for unmet needs in gastrointestinal disorders.

Medallia, Inc. Initiation

William Blair & Company initiated research coverage of Medallia, Inc. (MDLA $37.43). Medallia provides a leading experience management (EM) platform.